|
PSMD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.438790E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.004800E-03 |
| Normal-vs-Stage2 |
1.363570E-01 |
| Normal-vs-Stage3 |
1.46860000005411E-06 |
| Normal-vs-Stage4 |
5.28239999963986E-07 |
| Stage1-vs-Stage2 |
2.804600E-01 |
| Stage1-vs-Stage3 |
1.297560E-02 |
| Stage1-vs-Stage4 |
2.780900E-03 |
| Stage2-vs-Stage3 |
7.716000E-03 |
| Stage2-vs-Stage4 |
3.456000E-03 |
| Stage3-vs-Stage4 |
4.762200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.65919999999864E-05 |
| Normal-vs-AfricanAmerican |
5.147700E-02 |
| Normal-vs-Asian |
1.248000E-02 |
| Caucasian-vs-AfricanAmerican |
5.097600E-01 |
| Caucasian-vs-Asian |
3.244400E-01 |
| AfricanAmerican-vs-Asian |
9.529800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.58869999999212E-05 |
| Normal-vs-Female |
5.218600E-04 |
| Male-vs-Female |
3.163600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.059100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.000000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.92540000000441E-05 |
| Normal-vs-Age(81-100Yrs) |
3.805400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.388820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.906200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.771000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.398000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.567200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.309000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.279900E-02 |
| Classical-VS-Follicular |
6.670200E-01 |
| Classical-VS-Other |
3.469800E-01 |
| Classical-VS-Normal |
6.013200E-04 |
| Tall-VS-Follicular |
1.408300E-02 |
| Tall-VS-Other |
8.088600E-01 |
| Tall-VS-Normal |
1.68141999999927E-05 |
| Follicular-VS-Other |
3.615600E-01 |
| Follicular-VS-Normal |
1.955730E-02 |
| Other-VS-Normal |
2.169600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.716030E-03 |
| Normal-vs-N1 |
2.29439999999137E-05 |
| N0-vs-N1 |
8.753900E-02 |
|
|
